ATLAS / Macro Radar / Reporting / MAIA

MAIA Biotechnology, Inc. (MAIA) reporting calendar

MAIA Biotechnology, Inc. files periodic reports with the SEC as MAIA on NYSE. Atlas tracks 16 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
19 Jul 2026 – 1 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
16

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 41 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open MAIA market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll NYSE reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001493152-26-022154
10-K31 Dec 202523 Mar 202682 days0001493152-26-012088
10-Q30 Sep 20257 Nov 202538 days0001493152-25-021272
10-Q30 Jun 202511 Aug 202542 days0001641172-25-022899
10-Q31 Mar 20259 May 202539 days0000950170-25-068005
10-K31 Dec 202421 Mar 202580 days0000950170-25-043190
10-Q30 Sep 202412 Nov 202443 days0000950170-24-125474
10-Q30 Jun 20249 Aug 202440 days0000950170-24-094747
10-Q31 Mar 202414 May 202444 days0000950170-24-059550
10-K31 Dec 202321 Mar 202481 days0000950170-24-034764
10-Q30 Sep 20237 Nov 202338 days0000950170-23-059778
10-Q30 Jun 20238 Aug 202339 days0000950170-23-039399
10-Q31 Mar 20238 May 202338 days0000950170-23-018480
10-K31 Dec 202224 Mar 202383 days0000950170-23-009766
10-Q30 Sep 20229 Nov 202240 days0000950170-22-023956
10-Q30 Jun 202222 Aug 202253 days0000950170-22-017637

Source: SEC EDGAR company submissions for CIK 0001878313. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.